IR

Ingersoll Rand
D

IR

Arincen73/100B

Ingersoll Rand revenue 2012–2026

Ingersoll Rand's revenue in Q3 FY2026, the three months to 30 September 2026, was 2.06B USD, up 5.6% on the same quarter a year before. Ingersoll Rand's revenue over the last twelve months was 8.05B USD, up 8.0% on the twelve months before. In fiscal year 2025 it was 7.65B USD, up 5.7% on the year before.

Last updated 6 Nov 2026 · Next report 11 Feb 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 20268.05B+7.96%3.08B1.38B
FY202531 Dec 20257.65B+5.75%2.95B581.40M
FY202431 Dec 20247.24B+5.22%3.17B838.60M
FY202331 Dec 20236.88B+16.22%2.88B778.70M
FY202231 Dec 20225.92B+14.83%2.33B604.70M
FY202131 Dec 20215.15B+29.68%1.99B562.50M
FY202031 Dec 20203.97B+96.94%1.40B-33.30M
FY201931 Dec 20192.02B-24.99%778.30M159.10M
FY201831 Dec 20182.69B+13.24%1.01B269.40M
FY201731 Dec 20172.38B+22.48%897.90M18.40M
FY201631 Dec 20161.94B-8.82%716.70M-36.62M
FY201531 Dec 20152.13B-17.24%779.10M-351.20M
FY201431 Dec 20142.57B+9.11%936.78M-135.02M
FY201231 Dec 20122.36B—808.39M263.27M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Ingersoll Rand revenue growth by segment

Q3 FY2026 against Q3 FY2025

Industrial Technologies and Services1.62B
+5.2%
Precision and Science Technologies444.90M
+7.3%

Ingersoll Rand revenue by segment over time

Industrial Technologies and Services Precision and Science Technologies Energy Medical Industrials Aftermarket Original Equipment
Fiscal yearIndustrial Technologies and ServicesPrecision and Science TechnologiesEnergyMedicalIndustrialsAftermarketOriginal Equipment
FY20256.06B +4.1%1.59B +12.5%— — — — —
FY20245.82B +3.3%1.42B +14.0%— — — — —
FY20235.63B +19.7%1.24B +2.7%— — — — —
FY20224.71B +13.1%1.21B +22.2%— — — — —
FY20214.16B +28.1%991.40M +36.7%— — — — —
FY20203.25B 725.00M — — — — —
FY2019— — — — — 926.70M -12.1%1.53B -6.8%
FY2018— — — — — 1.05B 1.64B
FY2017— — 1.01B 230.20M 1.13B — —

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Ingersoll Rand's revenue

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.